Atypical opioid · serotonin–norepinephrine reuptake inhibitor

Tramadol and supplements: interactions, cautions, and safe stacks

Updated 2026-05-13 · Reviewed by SupplementScore editors · No sponsorships · No affiliate links

Tramadol is not a "regular" opioid. Its dual mechanism — mu-opioid agonism plus serotonin and norepinephrine reuptake inhibition — makes serotonergic supplements much more dangerous than they would be with morphine, oxycodone, or fentanyl. Multiple deaths have been reported with tramadol combined with kratom or strong serotonergic supplements. This is the opioid where the interaction list looks more like an SSRI's than like a typical opioid's.

Two parallel risks dominate tramadol's interaction profile. First, serotonin syndrome from co-administration with any serotonergic supplement (the SNRI half of tramadol is the issue). Second, respiratory depression from additive CNS sedation — the standard opioid concern, amplified by sedating supplements. Tramadol is also CYP2D6-activated, so anything that inhibits CYP2D6 (CBD, some botanicals) reduces analgesia by reducing conversion to the active metabolite O-desmethyltramadol.

Avoid combiningAvoid

5-HTP L-tryptophan St John's wort SAMe Saffron Rhodiola rosea Kratom Kava (high-dose extract)

5-HTP and L-tryptophan are direct serotonin precursors. Combined with tramadol's SNRI activity, multiple serotonin-syndrome case reports document this combination as one of the highest-risk SSRI/SNRI-adjacent pairings. PMID 37309284

St John's wort has both serotonergic activity and CYP3A4 induction; documented serotonin-syndrome cases with tramadol specifically. PMID 38025741

SAMe has serotonergic and methyl-donor activity and produces serotonin-syndrome cases when combined with any serotonergic prescription. PMID 12060836

Saffron and rhodiola rosea each have mild MAO-A inhibition. With tramadol's SRI activity, the additive serotonergic risk crosses the threshold from "discuss with your psychiatrist" (which is the rule for SSRIs) to "avoid" (which is the rule for tramadol, MAOIs, and other strongly serotonergic prescriptions). PMID 24299602; PMID 38025741

Kratom is itself a mu-opioid agonist with serotonergic activity. The combination has produced documented fatalities. Treat kratom + tramadol as a "do not combine, ever" pairing in clinical and educational contexts. PMID 38025741

Kava (high-dose extract) combines additive CNS depression with hepatotoxicity. Fatal respiratory depression has been reported when CNS depressants are combined with opioids; kava adds to that risk and contributes hepatotoxicity on top. PMID 38025741; FDA Consumer Advisory 2002

Caution / discuss with prescriberCaution

Korean red ginseng CBD (cannabidiol)

Korean red ginseng has monoaminergic effects and a theoretical additive serotonergic profile with tramadol. The risk is smaller than with the avoid-tier items but reasonable to discuss with your prescriber before stacking. PMID 38025741

CBD presents a two-edged problem with tramadol: (1) it inhibits CYP2D6, which reduces the conversion of tramadol to its more potent active metabolite — meaning less pain relief, not more; and (2) it adds CNS sedation. Patients sometimes assume CBD will "boost" their tramadol; mechanistically the opposite is more likely. PMID 38025741

Watch (modest signals)Watch

Melatonin (high-dose) Valerian root

Melatonin at standard doses (0.3–3 mg) is well-tolerated with tramadol. High-dose melatonin (5–10 mg) adds to CNS sedation, particularly in elderly patients where fall risk is the dominant downstream issue. Manufacturer label

Valerian root adds modest sedation; not as dangerous as kava but worth flagging at high extract doses. PMID 38025741

Often supportive / no problematic interactionSafe

Magnesium Omega-3

Magnesium at standard supplement doses has no pharmacokinetic or pharmacodynamic interaction with tramadol and is often useful for the constipation that opioid analgesia produces (magnesium citrate or magnesium oxide at low doses).

Omega-3 (fish oil, algal oil) has no clinically meaningful interaction with tramadol and may modestly contribute to background analgesia in chronic-pain syndromes.

Mechanism — why tramadol is different from other opioids

Tramadol's combined mu-opioid agonism plus serotonin/norepinephrine reuptake inhibition is what makes its interaction profile unusual:

SNRI activity — any serotonergic supplement adds to synaptic serotonin already being raised by tramadol. This is the same risk category as adding 5-HTP to an SSRI, except tramadol patients are typically not warned about it the way SSRI patients are. The serotonin-syndrome risk is real and concentrated in the first 1–2 weeks of any new serotonergic supplement.
CYP2D6 prodrug activation — tramadol becomes more effective when converted to O-desmethyltramadol. CYP2D6 inhibitors (some CBD preparations, paroxetine, fluoxetine, bupropion) reduce conversion and reduce analgesia. CYP2D6 ultra-rapid metabolizers convert too much and risk toxicity.
Mu-opioid agonism — like any opioid, additive CNS depression with sedative supplements raises respiratory-depression risk. Kava, kratom, and high-dose valerian/melatonin all sit in that additive category.

Of the common opioids, only meperidine has a similarly broad serotonergic interaction footprint. Morphine, oxycodone, hydrocodone, hydromorphone, and fentanyl are much safer to combine with serotonergic supplements (still requires care, but not the same magnitude of risk).

Recognising serotonin syndrome on tramadol

Symptoms include agitation, restlessness, tachycardia, hypertension, hyperthermia, sweating, tremor, hyperreflexia, and at the severe end clonus (especially elicited at the ankles), muscle rigidity, and altered mental status. Onset is typically within hours to days of the new combination. If you suspect serotonin syndrome, stop the supplement immediately and contact urgent care or your prescriber the same day. Severe presentations (hyperthermia, confusion, rigidity) are an emergency.

Practical guidance

Anyone prescribed tramadol who is using or considering any supplement on this page should have a single, deliberate conversation with their prescriber. Tramadol's interaction story is widely under-discussed in routine prescribing; you may need to raise it specifically. The list of "what I take" should include herbal products, mood/sleep supplements, and any cannabis-derived products — these are the ones most likely to interact and least likely to be captured in a standard med-rec.

Related class context

Tramadol's interaction profile is unique in the opioid class. Tapentadol is the only other commonly prescribed analgesic with similar serotonergic concerns. Codeine and hydrocodone share the CYP2D6-prodrug feature (so CBD/CYP2D6 inhibitors also reduce their efficacy), but lack the SNRI activity. See the opioid class overview for the broader comparison.

Sources

Janssen. Ultram (tramadol hydrochloride) prescribing information. US FDA label, accessed 2026-05. (Dual mu-opioid + monoamine reuptake mechanism; serotonin-syndrome warning.)
Foong AL, et al. Serotonin syndrome: practical clinical recognition and prevention. PMID: 37309284.
Asadi-Pooya AA, et al. Herbal–opioid interactions: a focused review including tramadol-specific cases. PMID: 38025741.
Iruela LM, et al. SAMe and serotonin syndrome: case reports and mechanism. PMID: 12060836.
Lopresti AL, Drummond PD. Saffron: serotonergic and MAO-A mechanisms. PMID: 24299602.
US Food and Drug Administration. Consumer advisory: kava-containing dietary supplements may be associated with severe liver injury, 2002.

Educational reference, not medical advice. Tramadol discontinuation should be supervised. If you suspect serotonin syndrome or respiratory depression while on tramadol, seek emergency care immediately.